SEC Tracker
Get the app

Rocket Pharmaceuticals RCKT

John Militello (Former Officer) plans to sell 8,923 RCKT shares, about $30,368

Form
144
Filed
Importance
Routine
  1. Approximate sale date: Sep 11, 2026
  2. Broker: Fidelity Brokerage Services LLC
  3. Shares acquired by: Restricted Stock Vesting

All of John Militello's insider filings, holdings and planned sales

Written from the Form 144 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Rocket Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Perspective Therapeutics CATX public float $213M, Jun 30, 2025
  2. Natures Sunshine Products NATR public float $211M, Jun 30, 2025
  3. Tvardi Therapeutics TVRD public float $207M, Jun 30, 2025
  4. Silence Therapeutics SLN public float $206M, Jun 30, 2025
  5. SELLAS Life Sciences Group SLS public float $219M, Jun 30, 2025